• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>International Journal of Clinical and Experimental Pathology >LRIG1 enhances the radiosensitivity of radioresistant human glioblastoma U251 cells via attenuation of the EGFR/Akt signaling pathway
【24h】

LRIG1 enhances the radiosensitivity of radioresistant human glioblastoma U251 cells via attenuation of the EGFR/Akt signaling pathway

机译：LRIG1通过减弱EGFR / Akt信号传导途径来增强人类抗放射胶质母细胞瘤U251细胞的放射敏感性

获取原文
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

The radiotherapy as a local and regional modality is widely applied in treatment of glioma, but most glioblastomas are commonly resistant to irradiation treatment. It remains challengeable to seek out efficient strategies to conquer the resistance of human glioblastoma cells to radiotherapy. Leucine-rich repeats and immunoglobulin-like domains protein 1 (LRIG1) is a newly discovered tumor suppressor which involved in regulation of chemosensitivity in various human cancer cells. In the present study, we established a radioresistant U251 cell line (U251R) to investigate the role of LRIG1 in regulation of radiosensitivity in human glioblastoma cells. Significantly decreased expression level of LRIG1 and enhanced expression of EGFR and phosphorylated Akt were detected in U251R cells compared with the parental U251 cells. U251R cells exhibited an advantage in colony formation ability, which accompanied by remarkably reduced X-ray-induced γ-H2AX foci formation and cell apoptosis. LRIG1 overexpression significantly inhibited the colony formation ability of U251R cells and obviously enhanced X-ray-inducedγ-H2AX foci formation and cell apoptosis. In addition, up-regulated expression of LRIG1 suppressed the expression level of EGFR and phosphorylated Akt protein. Our results demonstrated that LRIG1 expression was related to the radiosensitivity of human glioblastoma cells and may play an important role in the regulation of cellular radiosensitivity of human glioblastoma cells through the EGFR/Akt signaling pathway.
机译：作为局部和区域性方式的放射疗法被广泛地应用于神经胶质瘤的治疗中，但是大多数胶质母细胞瘤通常对放射治疗有抵抗力。寻找有效的策略来克服人类胶质母细胞瘤细胞对放射治疗的耐药性仍然是具有挑战性的。富含亮氨酸的重复序列和免疫球蛋白样结构域蛋白1（LRIG1）是一种新发现的肿瘤抑制因子，参与多种人类癌细胞的化学敏感性调节。在本研究中，我们建立了放射抗性U251细胞系（U251R），以研究LRIG1在调节人胶质母细胞瘤细胞放射敏感性中的作用。与亲本U251细胞相比，在U251R细胞中检测到LRIG1的表达水平显着降低，EGFR和磷酸化的Akt表达增强。 U251R细胞在集落形成能力方面表现出优势，伴随着X射线诱导的γ-H2AX灶形成和细胞凋亡的明显减少。 LRIG1过表达显着抑制U251R细胞的集落形成能力，并明显增强X射线诱导的γ-H2AX灶形成和细胞凋亡。另外，LRIG1的表达上调抑制了EGFR和磷酸化的Akt蛋白的表达水平。我们的结果表明，LRIG1表达与人胶质母细胞瘤细胞的放射敏感性有关，并且可能在通过EGFR / Akt信号通路调节人胶质母细胞瘤细胞的放射敏感性中起重要作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号